Manipulating immune responses with immunosuppressive agents that target NFAT.
Kiani
A
A
Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Germany.
Rao
A
A
Aramburu
J
J
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D019703:Calcineurin / Q000502:physiology; D020013:Calcium Signaling / Q000187:drug effects / Q000235:genetics; D016384:Consensus Sequence; D016572:Cyclosporine / Q000009:adverse effects / Q000494:pharmacology; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D004247:DNA / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000502:physiology; D015195:Drug Design; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007107:Immune System / Q000187:drug effects* / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D018448:Models, Immunological; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D010766:Phosphorylation / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D016559:Tacrolimus / Q000009:adverse effects / Q000494:pharmacology; D014157:Transcription Factors / Q000037:antagonists & inhibitors* / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects*
D016207:Cytokines; D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; D016572:Cyclosporine; D004247:DNA; D019703:Calcineurin; D016559:Tacrolimus